These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 821473)

  • 1. The effects of benzopyrene and safrole on biphenyl 2-hydroxylase and other drug-metabolizing enzymes.
    McPherson FJ; Bridges JW; Parke DV
    Biochem J; 1976 Mar; 154(3):773-80. PubMed ID: 821473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between cytochrome P-448 content and benzopyrene hydroxylase activity during the induction of microsomal monooxygenases using methylcholanthrene-type xenobiotics].
    Mishin VM; Makarova SI; Gutkina NI; Grishanova AIu; Liakhovich VV
    Biokhimiia; 1984 Mar; 49(3):464-9. PubMed ID: 6326866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of isosafrole in vivo with rat hepatic microsomal cytochrome P-450 following treatment with phenobarbitone or 20-methylcholanthrene.
    Fennell TR; Dickins M; Bridges JW
    Biochem Pharmacol; 1979 Apr; 28(8):1427-9. PubMed ID: 444308
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the properties in vitro of biphenyl 2- and 4-hydroxylase in the mesocarp from avocado pear (Persea americana) and Syrian-hamster hepatic tissue.
    McPherson FJ; Markham A; Bridges JW; Hartman GC; Parke DV
    Biochem Soc Trans; 1975; 3(2):281-3. PubMed ID: 1132558
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of cytochrome P-450c-mediated benzo[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole.
    Kao LR; Wilkinson CF
    Xenobiotica; 1987 Jul; 17(7):793-805. PubMed ID: 3660849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of various microsomal drug metabolizing components in tissue preparations from the livers, lungs, and small intestines of rodents.
    Tredger JM; Chhabra RS
    Drug Metab Dispos; 1976; 4(5):451-9. PubMed ID: 10144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of safrole and isosafrole pretreatment on N- and ring-hydroxylation of 2-acetamidofluorene by the rat and hamster.
    Lotlikar PD; Wasserman MB
    Biochem J; 1972 Oct; 129(4):937-43. PubMed ID: 4655827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the nature of the in vitro enhancement of biphenyl 2-hydroxylation provoked by some chemical carcinogens.
    McPherson FJ; Bridges JW; Parke DV
    Biochem Pharmacol; 1976 Jun; 25(12):1345-50. PubMed ID: 938557
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel haemoprotein induced by isosafrole pretreatment in the rat.
    Dickins M; Bridges JW; Elcombe CR; Netter KJ
    Biochem Biophys Res Commun; 1978 Jan; 80(1):89-96. PubMed ID: 623660
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective inhibition of the safrole-induced mixed-function oxidase activities by 9-hydroxyellipticine.
    Delaforge M; Ioannides C; Parke DV
    Chem Biol Interact; 1982 Dec; 42(3):279-89. PubMed ID: 7151231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of isosafrole as complexing agent and inducer of P-450LM4 in rabbit liver microsomes.
    Delaforge M; Koop DR; Coon MJ
    Biochem Biophys Res Commun; 1982 Sep; 108(1):59-65. PubMed ID: 6816232
    [No Abstract]   [Full Text] [Related]  

  • 12. An induction effect of phenobarbital on rat liver microsomal 4-hydroxylation of estradiol 17-sulfate.
    Watanabe K; Kimura R; Yoshizawa I
    J Pharmacobiodyn; 1984 Sep; 7(9):699-701. PubMed ID: 6527212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds.
    Creaven PJ; Parke DV
    Biochem Pharmacol; 1966 Jan; 15(1):7-18. PubMed ID: 4161076
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of both cytochromes P-450 and P-448 by 2,3',4,4',5-pentabromobiphenyl, a component of fireMaster.
    Robertson LW; Parkinson A; Safe S
    Biochem Biophys Res Commun; 1980 Jan; 92(1):175-82. PubMed ID: 6243934
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the kinetic parameters of the microsomal benzo(a)pyrene hydroxylase and the mutagenicity of benzo(a)pyrene in vitro [proceedings].
    Poncelet F; de Meester C; Roberfroid M; Mercier M
    Arch Int Physiol Biochim; 1978 May; 86(2):447-8. PubMed ID: 81022
    [No Abstract]   [Full Text] [Related]  

  • 17. Postnatal development of mixed-function oxidation as measured in microsomes from the small intestine and liver of rabbits.
    Tredger JM; Chhabra RS; Fouts JR
    Drug Metab Dispos; 1976; 4(1):17-24. PubMed ID: 3396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal xenobiotic metabolism in marsupials.
    McManus ME; Ilett KF
    Drug Metab Dispos; 1977; 5(6):503-10. PubMed ID: 21774
    [No Abstract]   [Full Text] [Related]  

  • 19. Species differences in the induction of microsomal hemoproteins and 3,4-benzpyrene hydroxylase by phenobarbital and 3-methylcholanthrene.
    Alvares AP; Schilling G; Levin W
    J Pharmacol Exp Ther; 1970 Oct; 175(1):4-11. PubMed ID: 5471452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spectral properties of cytochrome P450 following induction with phenobarbital, benzopyrene and methylcholanthrene].
    Remmer H; Greim G; Hildebrandt A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):189-90. PubMed ID: 4239220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.